The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-hydroxy-3-methoxybenzylamino)-N-(5-methylisoxazol-3-yl)benzenesulfonamide ID: ALA3113174
PubChem CID: 70701414
Max Phase: Preclinical
Molecular Formula: C18H19N3O5S
Molecular Weight: 389.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(CNc2ccc(S(=O)(=O)Nc3cc(C)on3)cc2)c1O
Standard InChI: InChI=1S/C18H19N3O5S/c1-12-10-17(20-26-12)21-27(23,24)15-8-6-14(7-9-15)19-11-13-4-3-5-16(25-2)18(13)22/h3-10,19,22H,11H2,1-2H3,(H,20,21)
Standard InChI Key: MAHHNZSNKYONTR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
11.1746 -17.5638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8396 -17.0902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5986 -16.3119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7803 -16.3010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5181 -17.0751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7409 -17.3196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7668 -14.9019 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.0291 -14.5373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0942 -15.3737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1787 -14.1967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0001 -14.1967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4128 -13.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0001 -12.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1787 -12.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7701 -13.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0907 -15.6595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4128 -12.0612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2341 -12.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6468 -11.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4681 -11.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8767 -10.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4681 -9.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6468 -9.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2341 -10.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6980 -10.6389 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1108 -9.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8767 -12.0612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
1 5 1 0
5 6 1 0
8 7 2 0
7 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
7 16 1 0
10 7 1 0
16 3 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
25 26 1 0
21 25 1 0
20 27 1 0
17 18 1 0
13 17 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.43Molecular Weight (Monoisotopic): 389.1045AlogP: 3.11#Rotatable Bonds: 7Polar Surface Area: 113.69Molecular Species: ACIDHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.15CX Basic pKa: 1.94CX LogP: 2.36CX LogD: 1.56Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -1.62
References 1. Luci DK, Jameson JB, Yasgar A, Diaz G, Joshi N, Kantz A, Markham K, Perry S, Kuhn N, Yeung J, Kerns EH, Schultz L, Holinstat M, Nadler JL, Taylor-Fishwick DA, Jadhav A, Simeonov A, Holman TR, Maloney DJ.. (2014) Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase., 57 (2): [PMID:24393039 ] [10.1021/jm4016476 ]